CompletedNot applicableNCT04084561
Official study title

Risk Communication in African American Smokers

Study summary

The study aims to understand the effects of learning about one's genetic risk for lung cancer that is specific to their ancestry. Participants will be given hypothetical personalized genetic risk results and ask to think about how they might respond to such information if they actually received such results.

Ask AI to explain this study
Start here

Key things to know

Main goalPrevention

This describes the study’s primary purpose.

What is being studiedHRHA and LRLA

Plus 2 other study approaches.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Dec 18, 2023 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?2 U.S. locations

Locations may change over time.

Who runs it?Temple University

Study sponsor

01
Study overview

What this study is about

Purpose
Prevention
Study type
Interventional
Phase
Not applicable
Sponsor
Temple University
Interventions being studied
Behavioral: HRHA; Behavioral: LRLA; Behavioral: HRLA; Behavioral: LRHA
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • 18 years of age minimum
  • Self-report African American
  • Report smoking at least 100 lifetime cigarettes
Reasons someone may not be able to joinExclusion criteria

Report history of cancer

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Hunter CollegeNew York, New York
  • Fox Chase Cancer CenterPhiladelphia, Pennsylvania

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Dec 18, 2023. Always confirm current availability with the study team.

View original record ↗